The Coronavirus Disease 2019 (COVID-19) pandemic has rapidly shifted health care needs
and delivery internationally, with about 1 in 5 people with COVID-19 requiring …

Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological
and virological characteristics are limited. In this case series, we describe the first 12 US …

Severe COVID-19 disease caused by SARS-CoV-2 is frequently accompanied by
dysfunction of the lungs and extrapulmonary organs. However, the organotropism of SARS …

An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …

In December 2019, an outbreak of viral pneumonia caused by a novel coronavirus (since
named SARS-CoV-2) was identified in Wuhan, China. Within few months, this disease–now …

The clinical spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection ranges from asymptomatic to critical illness, which may include severe sepsis and …

It is very exceptional that a new disease becomes a true pandemic. Since its emergence in
Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …

Since the outbreak and rapid spread of COVID-19 starting late December 2019, it has been
apparent that disease prognosis has largely been influenced by multiorgan involvement …

Background With the ongoing COVID-19 pandemic, growing evidence shows that a
considerable proportion of people who have recovered from COVID-19 have long-term …